Serum Amyloid A and Lipoprotein Retention in Murine Models of Atherosclerosis
- 1 April 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (4), 785-790
- https://doi.org/10.1161/01.atv.0000158383.65277.2b
Abstract
Objective— Elevated serum amyloid A (SAA) levels are associated with increased cardiovascular risk in humans. Because SAA associates primarily with lipoproteins in plasma and has proteoglycan binding domains, we postulated that SAA might mediate lipoprotein retention on atherosclerotic extracellular matrix. Methods and Results— Immunohistochemistry was performed for SAA, apolipoprotein A-I (apoA-I), apolipoprotein B (apoB), and perlecan on proximal aortic lesions from chow-fed low-density lipoprotein receptor (LDLR) −/− and apoE −/− mice euthanized at 10, 50, and 70 weeks. SAA was detected on atherosclerotic lesion extracellular matrix at all time points in both strains. SAA area correlated highly with lesion areas (apoE −/− , r =0.76; LDLR −/− , r =0.86), apoA-I areas (apoE −/− , r =0.88; LDLR −/− , r =0.80), apoB areas (apoE −/− , r =0.74; LDLR −/− , r =0.89), and perlecan areas (apoE −/− , r =0.83; LDLR −/− , r =0.79) (all P −/− and LDLR −/− mice demonstrated that SAA was present on both apoA-I–containing and apoB-containing lipoproteins. Conclusions— In chow-fed apoE −/− and LDLR −/− mice, SAA is deposited in murine atherosclerosis at all stages of lesion development, and SAA immunoreactive area correlates highly with lesion area, apoA-I area, apoB area, and perlecan area. These findings are consistent with a possible role for SAA-mediated lipoprotein retention in atherosclerosis.Keywords
This publication has 22 references indexed in Scilit:
- Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in WomenCirculation, 2004
- C-Reactive Protein Decreases Prostacyclin Release From Human Aortic Endothelial CellsCirculation, 2003
- The association of c-reactive protein, serum amyloid a and fibrinogen with prevalent coronary heart disease — baseline findings of the PAIS projectAtherosclerosis, 2001
- The Heparin/Heparan Sulfate-binding Site on Apo-serum Amyloid AJournal of Biological Chemistry, 1999
- Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.JCI Insight, 1996
- Transgenic Mice That Overexpress Mouse Apolipoprotein B: EVIDENCE THAT THE DNA SEQUENCES CONTROLLING INTESTINAL EXPRESSION OF THE APOLIPOPROTEIN B GENE ARE DISTANT FROM THE STRUCTURAL GENEPublished by Elsevier BV ,1996
- The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A proteinImmunology Today, 1994
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- Lipoprotein lipase is synthesized by macrophage-derived foam cells in human coronary atherosclerotic plaques.JCI Insight, 1992
- Superoxide-mediated modification of low density lipoprotein by arterial smooth muscle cells.JCI Insight, 1986